Background Research describing male breast cancer with HER2 overexpression is limited.
This study evaluated the characteristics, treatment, and outcomes of HER2 positive breast …

Male breast cancer (MBC) is uncommon in clinical practice. Using the 21-gene assay to
facilitate decision-making on comprehensive treatment of MBC is rarely reported. This study …

Background Male breast cancer (MBC) is an uncommon and relatively uncharacterised
disease accounting for< 1% of all breast cancers. A significant proportion occurs in families …

Objectives: A clinicopathologic study with an emphasis on tumor immunohistochemical
profile is presented. Methods: Sixty-one cases of male invasive breast cancers were studied …

The aim of this study is to evaluate the prognostic values of some biological parameters in a
population based series of female breast cancer patients. Through the Tuscan Cancer …

Male breast cancer (MBC) is extremely rare and accounts for less than 1% of all breast
malignancies. Therefore, clinical management of MBC is currently guided by research on …

Background The male breast cancer (MBC) is a rare and represents less than 1% of all
malignancies in men and only 1% of all breast cancers incident. We illustrate the experience …

Although the majority of breast cancers affect women, approximately 1% of cases occur in
men. At present comparatively little is known about the molecular mechanisms that influence …

Context.—The rate of male breast cancer is a small fraction of that observed in females, thus
severely limiting our understanding of the pathogenesis of this condition. It remains unclear …

Male breast carcinoma - PMC Back to Top Skip to main content NIH NLM Logo Access keys
NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text …